PRM23 - MODELLING CANCER TREATMENTS IN THE ADJUVANT SETTING: A TARGETED LITERATURE REVIEW (TLR) OF TECHNOLOGY APPRAISALS (TA) OF ADJUVANT THERAPIES SUBMITTED TO THE NATIONAL INSTIT... von Batteson, R, Hemstock, M, Hart, R, Saunders, O, Kotapati, S, Gooden, KM, Amadi, A

Volltext

PCN187 - Patterns Of Second-Line (2L) Treatment For Metastatic Urothelial Cancer (MUC) In Canada von Jaffe, DH, DeCongelio, M, Li, VW, Lakhdari, K, Goulden, S, Gooden, KM

Volltext

Patterns Of Second-Line (2L) Treatment For Metastatic Urothelial Cancer (MUC) In Canada von Jaffe, DH, DeCongelio, M, Li, VW, Lakhdari, K, Goulden, S, Gooden, KM

Volltext

Treatment Patterns Of Second-Line (2L) Metastatic Urothelial Cancer (MUC) In Spain von Clark, OA, Jaffe, D, DeCongelio, M, Li, VW, Goulden, S, Gonzalez, P, Gooden, KM

Volltext

PCN342 - Treatment Patterns Of Second-Line (2L) Metastatic Urothelial Cancer (MUC) In Spain von Clark, OA, Jaffe, D, DeCongelio, M, Li, VW, Goulden, S, Gonzalez, P, Gooden, KM

Volltext

PRM20 - Chi-Square Automatic Interaction Detection (CHAID) Analysis: Understanding and Informing Treatment Choice of Second-Line Metastatic Urothelial Cancer Therapy von Jaffe, DH, Kwan, J, Li, VW, Li, S, DeCongelio, M, Pomerantz, D, Hoover, C, Goulden, S, Gooden, KM

Volltext

Chi-Square Automatic Interaction Detection (CHAID) Analysis: Understanding and Informing Treatment Choice of Second-Line Metastatic Urothelial Cancer Therapy von Jaffe, DH, Kwan, J, Li, VW, Li, S, DeCongelio, M, Pomerantz, D, Hoover, C, Goulden, S, Gooden, KM

Volltext

PRM21 - MODELLING SURVIVAL OF PATIENTS WITH COMPLETELY RESECTED ADVANCED MELANOMA WITH ADJUVANT TREATMENT OF NIVOLUMAB VERSUS OBSERVATION von Batteson, R, Hemstock, M, Hart, R, Kotapati, S, Gooden, KM, Amadi, A

Volltext

Determination of Isomeric Dibenzo[ a, l]pyrene-Adenine Adducts by Six Different Tandem Mass Spectrometric Experiments von Byun, Jaeman, Gooden, Jonathon, Ramanathan, Ragulan, Li, Kai-Ming, Cavalieri, Ercole L., Gross, Michael L.

Volltext